These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 7588822)

  • 1. Role of antigenemia assay in the early diagnosis and prediction of human cytomegalovirus organ involvement in AIDS patients.
    Francisci D; Tosti A; Preziosi R; Baldelli F; Stagni G; Pauluzzi S
    Eur J Clin Microbiol Infect Dis; 1995 Jun; 14(6):498-503. PubMed ID: 7588822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic significance and clinical impact of quantitative assays for diagnosis of human cytomegalovirus infection/disease in immunocompromised patients.
    Gerna G; Percivalle E; Baldanti F; Sarasini A; Zavattoni M; Furione M; Torsellini M; Revello MG
    New Microbiol; 1998 Jul; 21(3):293-308. PubMed ID: 9699213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of late pp67-mRNA by NASBA in peripheral blood for the diagnosis of human cytomegalovirus disease in AIDS patients.
    Blank BS; Meenhorst PL; Pauw W; Mulder JW; van Dijk WC; Smits PH; Roeles F; Middeldorp JM; Lange JM
    J Clin Virol; 2002 Jul; 25(1):29-38. PubMed ID: 12126719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of a quantitative cytomegalovirus (CMV) antigenemia test in evaluating HIV+ patients with and without CMV disease.
    Wetherill PE; Landry ML; Alcabes P; Friedland G
    J Acquir Immune Defic Syndr Hum Retrovirol; 1996 May; 12(1):33-7. PubMed ID: 8624758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early virus isolation, early structural antigen detection and DNA amplification by the polymerase chain reaction in polymorphonuclear leukocytes from AIDS patients with human cytomegalovirus viraemia.
    Gerna G; Zipeto D; Parea M; Percivalle E; Zavattoni M; Gaballo A; Milanesi G
    Mol Cell Probes; 1991 Oct; 5(5):365-74. PubMed ID: 1665208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical usefulness of human cytomegalovirus antigenemia assay after kidney transplantation.
    Kim CK; Song JH; Kim SM; Peck KR; Oh W; Huh W; Kim YG; Kim SJ; Joh JW; Lee NY; Park CG; Hwang ES; Cha CY; Oh HY
    Transplantation; 2003 Jun; 75(12):2151-5. PubMed ID: 12829929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Significance of cytomegalovirus (CMV)-pp65 antigenemia in the diagnosis of CMV disease in human immunodeficiency virus-infected patients.
    Reynes J; Montes B; Atoui N; Segondy M
    J Med Virol; 1996 Jul; 49(3):195-8. PubMed ID: 8818964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinically-based determination of safe DNAemia cutoff levels for preemptive therapy or human cytomegalovirus infections in solid organ and hematopoietic stem cell transplant recipients.
    Lilleri D; Baldanti F; Gatti M; Rovida F; Dossena L; De Grazia S; Torsellini M; Gerna G
    J Med Virol; 2004 Jul; 73(3):412-8. PubMed ID: 15170637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Usefulness of the cytomegalovirus (CMV) antigenemia assay for predicting the occurrence of CMV disease and death in patients with AIDS.
    Chevret S; Scieux C; Garrait V; Dahel L; Morinet F; Modaï J; Decazes JM; Molina JM
    Clin Infect Dis; 1999 Apr; 28(4):758-63. PubMed ID: 10825035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Standardization of Antigenemia and qPCR Cut-off Values in Whole Blood for the Detection of Cytomegalovirus Disease in HIV Patients.
    Carstensen S; Raboni SM; França JCB; Teixeira F
    Rev Soc Bras Med Trop; 2019 Jun; 52():e20180457. PubMed ID: 31271616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative pp65-antigenemia assay for the prediction of human cytomegalovirus disease in HIV-infected patients.
    Blank BS; Meenhorst PL; Weverling GJ; Stout-Zonneveld AA; Pauw W; Mulder JW; van Dijk WC; Smits P; Lange JM
    AIDS; 1999 Dec; 13(18):2533-9. PubMed ID: 10630522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of antigenemia assay for the diagnosis of cytomegalovirus gastrointestinal diseases in HIV-infected patients.
    Hamada Y; Nagata N; Shimbo T; Igari T; Nakashima R; Asayama N; Nishimura S; Yazaki H; Teruya K; Gatanaga H; Kikuchi Y; Akiyama J; Ohmagari N; Uemura N; Oka S
    AIDS Patient Care STDS; 2013 Jul; 27(7):387-91. PubMed ID: 23799239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic value of antigenemia assay for cytomegalovirus gastrointestinal disease in immunocompromised patients.
    Nagata N; Kobayakawa M; Shimbo T; Hoshimoto K; Yada T; Gotoda T; Akiyama J; Oka S; Uemura N
    World J Gastroenterol; 2011 Mar; 17(9):1185-91. PubMed ID: 21448424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of pp65 antigenemia, quantitative PCR and DNA hybrid capture for detection of cytomegalovirus in transplant recipients and AIDS patients.
    Mhiri L; Kaabi B; Houimel M; Arrouji Z; Slim A
    J Virol Methods; 2007 Jul; 143(1):23-8. PubMed ID: 17336402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A quantitative test (HCMV-hybrid-capture(TM)) to detect human cytomegalovirus DNA in the blood of immunocompromised patients compared with antigenemia and polymerase chain reaction.
    Lazzarotto T; Campisi T; Dal Monte P; Galli S; Spezzacatena P; Guglielmi P; Landini MP
    New Microbiol; 1996 Jul; 19(3):193-201. PubMed ID: 8841034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of the cytomegalovirus antigenemia (CMV-Ag) assay for the detection of CMV in the blood of AIDS patients.
    Lipson SM; Kaplan MH; Tseng LF; Mandel FS
    Can J Microbiol; 1993 Nov; 39(11):1059-65. PubMed ID: 8306207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Investigation of cytomegalovirus positivity in the peripheral blood samples of risky patients by shell-vial cell culture, antigenemia test and real-time polymerase chain reaction].
    Gökahmetoğlu S; Yağmur G; Mutlu Sarıgüzel F; Deniz E
    Mikrobiyol Bul; 2011 Apr; 45(2):288-95. PubMed ID: 21644072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictive value of cytomegalovirus (CMV) antigenemia and digene hybrid capture DNA assays for CMV disease in human immunodeficiency virus-infected patients.
    Walmsley S; O'Rourke K; Mortimer C; Rachlis A; Fong I; Mazzulli T
    Clin Infect Dis; 1998 Sep; 27(3):573-81. PubMed ID: 9770159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The prognostic value of cytomegalovirus antigenemia and viremia for the development of cytomegalovirus disease and the survival of AIDS patients].
    Cartón JA; Maradona JA; de Oña M; Asensi V; Melón S; García-Alcalde ML; Rodríguez-Junquera M; Moreno-Torrico A; de Zárraga M
    Med Clin (Barc); 1999 Sep; 113(6):205-9. PubMed ID: 10472608
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative analysis of a double primer PCR assay with plasma, leukocytes and antigenemia for diagnosis of active human cytomegalovirus infection in bone marrow transplant patients.
    Yaghobi R; Behzad-Behbahani A; Sabahi F; Roustaee MH; Alborzi A; Ramzi M; Nourani H
    Bone Marrow Transplant; 2005 Mar; 35(6):595-9. PubMed ID: 15665849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.